Pancreatic cystadenoma

Summary

Pancreatic cystadenoma (MONDO:0002809) is a disease and 3 clinical trials. A subtype of cystadenoma — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Clinical trials: 3

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	pancreatic cystadenoma
Mondo ID	MONDO:0002809
DOID	DOID:3918
NCIT	C4374
SNOMED CT	235967003
UMLS	C0341486
MedGen	90963
Anatomy (UBERON)	UBERON:0000017
Is cancer (heuristic)	no

Also known as: cystadenoma of pancreas · cystadenoma of the pancreas · exocrine pancreas cystadenoma

Disease family

This is a subtype of cystadenoma. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by etiologic mechanism › cancer or benign tumor › neoplastic disease or syndrome › neoplasm › epithelial neoplasm › adenoma › cystadenoma › pancreatic cystadenoma

Related subtypes (6): bile duct cystadenoma, seminal vesicle cystadenoma, serous cystadenoma, ovarian cystadenoma, mucinous cystadenoma, papillary cystadenoma

Subtypes (2): pancreatic serous cystadenoma, pancreatic mucinous cystadenoma

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 3.

Phase distribution (across all retrieved trials)

Phase	Trials
PHASE2/PHASE3	1
PHASE1	1
Not specified	1

Top trials by phase / activity

NCT	Phase	Status	Title
NCT00233038	PHASE2/PHASE3	COMPLETED	EUS-Guided Pancreatic Injection of Cyst (EPIC) Trial
NCT03147768	PHASE1	COMPLETED	Laser Tissue Welding - Distal Pancreatectomy Sealing Study
NCT06939023	Not specified	RECRUITING	Laparoscopic Versus Robot-assisted Left-sided Pancreatectomy for Benign and Pre-malignant Lesions (DIPLOMA-3)